TP53 and cancer: We also identified mechanisms of HO-3867 action beyond directly targeting p53, including other pro-apoptotic pathways, the inhibition of DNA repair and induction of the DNA damage response, and immunomodulatory pathways, thereby broadening the potential use of this compound even in p53 null cancers.